Cyclophosphamide-d8
For Laboratory Research Only. Not for Clinical or Personal Use.
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Cyclophosphamide-d8
Description :
Cyclophosphamide-d8 is deuterium labeled Cyclophosphamide. Cyclophosphamide is a synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic activity, a immunosuppressant.UNSPSC :
12352005Target :
DNA Alkylator/Crosslinker; Isotope-Labeled CompoundsType :
Isotope-Labeled CompoundsRelated Pathways :
Cell Cycle/DNA Damage; OthersApplications :
Cancer-programmed cell deathField of Research :
CancerSolubility :
10 mM in DMSOSmiles :
ClC([2H])([2H])C([2H])([2H])N(P1(NCCCO1)=O)C([2H])([2H])C([2H])([2H])ClMolecular Formula :
C7H7D8Cl2N2O2PMolecular Weight :
269.14References & Citations :
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]al-Jafari AA, et al. Inhibition of human acetylcholinesterase by cyclophosphamide. Toxicology. 1995 Jan 19;96 (1) :1-6.|[3]Harris RN, et al. Carbon tetrachloride-induced increase in the antitumor activity of cyclophosphamide in mice: a pharmacokineticstudy. Cancer Chemother Pharmacol. 1984;12 (3) :167-72.|[4]Liu P, et al. Administration of cyclophosphamide changes the immune profile of tumor-bearing mice. J Immunother. 2010 Jan;33 (1) :53-9.|[5]Schwartz PS, et al. Cyclophosphamide induces caspase 9-dependent apoptosis in 9L tumor cells. Mol Pharmacol. 2001 Dec;60 (6) :1268-1279.Shipping Conditions :
Room temperatureScientific Category :
Isotope-Labeled CompoundsClinical Information :
No Development ReportedCAS Number :
[1178903-96-2]

